1. Home
  2. FATE vs DERM Comparison

FATE vs DERM Comparison

Compare FATE & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.25

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

DERM

Journey Medical Corporation

HOLD

Current Price

$5.03

Market Cap

135.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FATE
DERM
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.6M
135.3M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
FATE
DERM
Price
$1.25
$5.03
Analyst Decision
Buy
Strong Buy
Analyst Count
6
3
Target Price
$4.10
$12.67
AVG Volume (30 Days)
1.2M
187.9K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
29.88
34.72
EPS
N/A
N/A
Revenue
$6,646,000.00
$61,858,000.00
Revenue This Year
N/A
$39.72
Revenue Next Year
N/A
$63.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.20
52 Week Low
$0.91
$4.31
52 Week High
$1.94
$9.56

Technical Indicators

Market Signals
Indicator
FATE
DERM
Relative Strength Index (RSI) 46.34 38.37
Support Level $0.95 $4.31
Resistance Level $1.30 $5.60
Average True Range (ATR) 0.08 0.26
MACD -0.01 0.10
Stochastic Oscillator 14.89 15.71

Price Performance

Historical Comparison
FATE
DERM

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: